Browse

New! Learn more about the all new DeepDyve personalized home page where you can quickly skim your favorite journals all from one place

Current Opinion in Immunology

2012
- Volume 24
  - Issue 2 (Apr)
  - Issue 1 (Feb)
2011
- Volume 23
2010
- Volume 22
2009
- Volume 21
2008
- Volume 20
2007
- Volume 19
2006
- Volume 18
2005
- Volume 17
2004
- Volume 16
2003
- Volume 15
2002
- Volume 14
2001
- Volume 13
2000
- Volume 12
1999
- Volume 11
1998
- Volume 10
1997
- Volume 9
1996
- Volume 8
1995
- Volume 7

Bookmark
More Like This EQa3cDJhej $0.99

Transcriptional drivers of the T-cell lineage program

Rothenberg, Ellen V

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012
Bookmark
More Like This f56Og59W4F $0.99

Editors, Issue sections

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012
Bookmark
More Like This 8hKH8p3xS4 $0.99

Modulation of GITR for cancer immunotherapy

Schaer, David A; Murphy, Judith T; Wolchok, Jedd D

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012
Bookmark
More Like This nXr0eJu89O $0.99

Liberating tumor immunity

Meyaard, Linde

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012
Bookmark
More Like This gkHUsJxM0B $0.99

NK cell MHC class I specific receptors (KIR): from biology to clinical intervention

Thielens, Ariane; Vivier, Eric; Romagné François

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012
Bookmark
More Like This m0PffycSsi $0.99

Making memory at birth: understanding the differentiation of natural killer T cells

Engel, Isaac; Kronenberg, Mitchell

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012
Bookmark
More Like This sBMx69A31s $0.99

The many roles of TOX in the immune system

Aliahmad, Parinaz; Seksenyan, Akop; Kaye, Jonathan

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012
Bookmark
More Like This 0LiXtmRObL $0.99

Tim-3, a negative regulator of anti-tumor immunity

Anderson, Ana Carrizosa

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012
Bookmark
More Like This q3hkd1dJ4e $0.99

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity

Topalian, Suzanne L; Drake, Charles G; Pardoll, Drew M

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012
Bookmark
More Like This yJv8qSGZjx $0.99

Contents, Cover details

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

About DeepDyve

DeepDyve provides simple and affordable access to millions of articles across thousands of peer-reviewed journals. Content from the world's leading publishers including Reed Elsevier, Springer, Wiley-Blackwell, and more. DeepDyve — the simplest way to get the articles you need.
Rent from the Cloud - starting at $0.99
With DeepDyve, you can "rent" and read an article through your browser— for as little as $0.99. What exactly is "renting"? Renting an article means you can read the full article as often as you like until it expires (7 days or longer), but it cannot be downloaded or printed. Renting allows you to save up to 90%, so you can read articles without the worry.

"Rent to Own" — Buy PDF's, Save up to 20%
With DeepDyve's monthly plans (starting at $5.99), you not only get savings on rentals, you also receive 20% discount coupons for your PDF purchases. What happens if you don't use all your rental tokens or coupons this month? No problem, they automatically roll-over so you can stockpile them for when you need them.
14-day Risk Free Trial — Commitment Free, Cancel Anytime

Still thinking it over? Then try our service for free for 14 days. You can cancel at any time within the trial, no questions asked, and your credit card will not be billed. Should you continue with our service beyond the trial, you will only be charged month-to-month, so you can still cancel at any time — there's no contract or long-term commitment.
Privacy and Security

DeepDyve values your privacy and security. We will never sell your personal information to any third party.

Sign Up for a DeepDyve Account

Bookmark an Article

To bookmark an article, please log in first, or sign up for a DeepDyve account if you don't already have one.

Subscribe to Journal Email Alerts

To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don't already have one.

Please refresh to generate a new download link

Your article download link has expired. Please refresh this page to obtain a new download link and try again.

Follow a Journal

To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don't already have one.

Current Opinion in Immunology

Transcriptional drivers of the T-cell lineage program

Rothenberg, Ellen V

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

Editors, Issue sections

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

Modulation of GITR for cancer immunotherapy

Schaer, David A; Murphy, Judith T; Wolchok, Jedd D

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

Liberating tumor immunity

Meyaard, Linde

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

NK cell MHC class I specific receptors (KIR): from biology to clinical intervention

Thielens, Ariane; Vivier, Eric; Romagné François

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

Making memory at birth: understanding the differentiation of natural killer T cells

Engel, Isaac; Kronenberg, Mitchell

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

The many roles of TOX in the immune system

Aliahmad, Parinaz; Seksenyan, Akop; Kaye, Jonathan

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

Tim-3, a negative regulator of anti-tumor immunity

Anderson, Ana Carrizosa

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity

Topalian, Suzanne L; Drake, Charles G; Pardoll, Drew M

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

Contents, Cover details

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

Welcome to DeepDyve

About

Support

About DeepDyve

14-day Risk Free Trial — Commitment Free, Cancel Anytime

Privacy and Security

Bookmark an Article

Subscribe to Journal Email Alerts

Please refresh to generate a new download link

Follow a Journal

Advanced Filters:

Specific Data Sources:

Current Opinion in Immunology

1 - 10 of 22 articles

Follow Current Opinion in Immunology , Volume 24 (2) Elsevier – Apr 1, 2012

Follow Current Opinion in Immunology , Volume 24 (2) Elsevier – Apr 1, 2012

Schaer, David A; Murphy, Judith T; Wolchok, Jedd D

Follow Current Opinion in Immunology , Volume 24 (2) Elsevier – Apr 1, 2012

Follow Current Opinion in Immunology , Volume 24 (2) Elsevier – Apr 1, 2012

Thielens, Ariane; Vivier, Eric; Romagné François

Follow Current Opinion in Immunology , Volume 24 (2) Elsevier – Apr 1, 2012

Engel, Isaac; Kronenberg, Mitchell

Follow Current Opinion in Immunology , Volume 24 (2) Elsevier – Apr 1, 2012

Aliahmad, Parinaz; Seksenyan, Akop; Kaye, Jonathan

Follow Current Opinion in Immunology , Volume 24 (2) Elsevier – Apr 1, 2012

Follow Current Opinion in Immunology , Volume 24 (2) Elsevier – Apr 1, 2012

Topalian, Suzanne L; Drake, Charles G; Pardoll, Drew M

Follow Current Opinion in Immunology , Volume 24 (2) Elsevier – Apr 1, 2012

Follow Current Opinion in Immunology , Volume 24 (2) Elsevier – Apr 1, 2012

About DeepDyve

14-day Risk Free Trial — Commitment Free, Cancel Anytime

Privacy and Security

Bookmark an Article

Subscribe to Journal Email Alerts

Please refresh to generate a new download link

Follow a Journal

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012

Follow Current Opinion in Immunology , Volume 24 (2)
Elsevier – Apr 1, 2012